Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway-Reference-Cited by-同舟云学术

Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway

Published:2021-07-29 Issue:4 Volume:22 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Zhan Lan¹,Wang Xiangxiu¹,Zhang Yanjing¹,Zhu Guonian¹,Ding Yu¹,Chen Xuemei¹,Jiang Wei²,Wu Sisi¹

Affiliation:

1. Core Facilities, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

2. Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review;Current Treatment Options in Oncology;2024-07-27

2. Differences in Levels of Mitochondrial DNA Content at Various Stages of Canine Myxomatous Mitral Valve Disease;Animals;2023-12-14

3. Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms;Environmental Research;2023-10

4. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy;Biomedicine & Pharmacotherapy;2022-12

5. PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K/AKT phosphorylation;International Immunopharmacology;2022-12